Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-15-000714
Filing Date
2015-02-10
Accepted
2015-02-10 16:00:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5_021015.htm 424B5 1092667
2 logo.jpg GRAPHIC 39120
3 pipeline.jpg GRAPHIC 127818
  Complete submission text file 0001171843-15-000714.txt   1323810
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 424B5 | Act: 33 | File No.: 333-193503 | Film No.: 15593800
SIC: 2834 Pharmaceutical Preparations